Short Interest in Jamieson Wellness Inc. (OTCMKTS:JWLLF) Increases By 419.6%

Jamieson Wellness Inc. (OTCMKTS:JWLLF) was the recipient of a large growth in short interest in July. As of July 31st, there was short interest totaling 404,709 shares, a growth of 419.6% from the July 15th total of 77,891 shares. Based on an average daily volume of 12,221 shares, the days-to-cover ratio is currently 33.1 days.

Wall Street Analyst Weigh In

Several brokerages have weighed in on JWLLF. Royal Bank Of Canada downgraded Jamieson Wellness from an “outperform” rating to a “sector perform” rating in a report on Monday. Citigroup cut Jamieson Wellness to a “hold” rating in a research note on Friday. National Bank Financial restated an “outperform” rating on shares of Jamieson Wellness in a research note on Friday, June 26th. Finally, Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of Jamieson Wellness in a research note on Friday, May 8th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Jamieson Wellness presently has an average rating of “Moderate Buy”.

Jamieson Wellness Trading Up 0.2%

Shares of JWLLF stock opened at $32.76 on Wednesday. The firm has a fifty day moving average price of $28.46 and a 200 day moving average price of $26.51. Jamieson Wellness has a 12 month low of $23.88 and a 12 month high of $32.76.

Jamieson Wellness Company Profile

Jamieson Wellness is a leading Canadian manufacturer and distributor of nutraceutical products, including vitamins, minerals, herbal remedies and dietary supplements. Founded in 1922, the company has grown to offer a diverse portfolio of formulations designed to support general health, immune function, digestion and other specialized wellness needs. Its flagship Jamieson brand is complemented by sub-brands such as bkind, reflecting a commitment to innovation and consumer choice across a range of tablet, capsule and gummy formats.

The company serves both domestic and international markets through a multi-channel approach that includes major mass and drug retailers, specialty stores and direct-to-consumer e-commerce platforms.